AI-Supported Video Education in Episiotomy Care

March 5, 2026 updated by: Mine Gokduman Keles, Burdur Mehmet Akif Ersoy University

The Effect of an Artificial Intelligence-Assisted Video Education Program on Episiotomy Wound Healing, Pain, and Dyspareunia: A Randomized Controlled Trial"

Although the postpartum period is generally considered a positive experience, obstetric interventions such as episiotomy may lead to significant maternal health problems. Episiotomy, a surgical incision performed on the perineum during the second stage of labor, remains widely used despite World Health Organization recommendations to limit its rate. Episiotomy-related complications, including pain, infection, bleeding, and dyspareunia, can negatively affect wound healing, quality of life, and postpartum sexual health. Proper episiotomy wound care and education are therefore essential components of postpartum care. This study aims to evaluate the effect of an artificial intelligence-supported video education on episiotomy wound healing and postpartum sexual quality of life. The findings are expected to contribute to improved postpartum care practices and guide future research in this field.

Study Overview

Status

Not yet recruiting

Detailed Description

Although the postpartum period is generally considered a positive experience for mothers, obstetric interventions such as episiotomy may lead to various health problems. Episiotomy, defined as a strategic surgical incision made in the perineum during the second stage of labor, remains a fundamental obstetric intervention (WHO, 2018). Despite the World Health Organization's recommendation to reduce episiotomy rates in normal vaginal births to 10%, this procedure is still performed in approximately 30-50% of women (WHO, 2018), and post-episiotomy perineal discomfort has been reported in 42% of women (Roma et al., 2023).

Episiotomy may result in bleeding, infection, and postpartum pain associated with an increased risk of dyspareunia, thereby negatively affecting women's quality of life and sexual health (Hartinah et al., 2021). Minimizing these adverse outcomes requires preventing chronic pain, supporting mothers in effective pain management, preventing constipation, monitoring urinary retention, and reducing the risk of infection (Hartinah et al., 2021).

Evidence indicates that keeping the episiotomy wound dry, compared with sitz baths, reduces postpartum pain, accelerates wound healing, and positively influences postpartum sexual function (Alirezaei et al., 2024; Roma et al., 2023; Brezeanu et al., 2025; Aydemir et al., 2024). Therefore, education on episiotomy wound care constitutes a critical component of postpartum care.

The aim of this study is to evaluate the effect of an artificial intelligence-supported video education on episiotomy wound healing and postpartum sexual quality of life. Additionally, the study seeks to determine the impact of AI-supported video education on episiotomy wound healing, pain, and dyspareunia among postpartum women and to provide a foundation for future research in this field.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

18 years of age and older,

  • No high-risk pregnancy (no systemic disease, no smoking, no postpartum complications),
  • Gestational age 37-42 weeks,
  • Single vaginal delivery of live birth,
  • Mediolateral episiotomy,
  • Not taking any medication,
  • No other lacerations besides episiotomy (anal sphincter injury, 3rd degree perineal laceration).
  • Single vaginal delivery of live birth or single vaginal delivery without episiotomy, age between 18-35 years, sexually active and healthy
  • Primiparous pregnant women

Exclusion Criteria:

  • • Mothers who have had multiple, stillbirth, or anomalous births,

    • Mothers who refuse home visits will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: INTERVENTION 1
Women allocated to the intervention group will receive an AI-assisted video-based educational intervention on episiotomy care in addition to routine postpartum care.
Women in the intervention group will receive routine postpartum care and an AI-assisted educational video about effective breastfeeding within the first 30 minutes after birth. The video includes information on the importance of early breastfeeding, correct breastfeeding positions, and techniques to increase milk production.
Other: Control
Routine postpartum care
Women in the control group will receive routine postpartum and episiotomy care provided by midwives before discharge, in accordance with standard hospital practices. No additional educational or AI-assisted video intervention will be provided to this group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
(REEDA Scale)
Time Frame: Postpartum Day 1, Day 3, Day 5, Day 7, and Day 14
Episiotomy wound healing will be evaluated using the REEDA Scale, which assesses five components: redness, edema, ecchymosis, discharge, and approximation of wound edges.
Postpartum Day 1, Day 3, Day 5, Day 7, and Day 14
Episiotomy wound healing score (REEDA Scale)
Time Frame: Postpartum day 1, day 3, day 5, day 7, and day 14
Episiotomy wound healing will be assessed using the REEDA Scale, which evaluates five components: redness, edema, ecchymosis, discharge, and approximation of wound edges
Postpartum day 1, day 3, day 5, day 7, and day 14
Perineal pain intensity (Visual Analog Scale - VAS)
Time Frame: Postpartum day 1, day 3, day 5, day 7, and day 14
Perineal pain intensity will be measured using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will indicate their perceived pain intensity on the scale.
Postpartum day 1, day 3, day 5, day 7, and day 14

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum sexual function and dyspareunia score (Carol Postpartum Sexual Function and Dyspareunia Scale)
Time Frame: Postpartum 3 months after resumption of vaginal intercourse
Postpartum sexual function and dyspareunia will be evaluated using the Carol Postpartum Sexual Function and Dyspareunia Scale, which assesses readiness for sexual activity, vulvar discomfort, pain during vaginal intercourse, and pain after intercourse
Postpartum 3 months after resumption of vaginal intercourse

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 2, 2026

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

December 19, 2025

First Submitted That Met QC Criteria

March 5, 2026

First Posted (Actual)

March 6, 2026

Study Record Updates

Last Update Posted (Actual)

March 6, 2026

Last Update Submitted That Met QC Criteria

March 5, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Kahramanmaraş Sütçü İmam Ünive

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Perineal Pain

Clinical Trials on AI-Assisted Episiotomy Care Video Group

Subscribe